the first step to solving a problem is acknowledging you have a problem.
second step is doing something about it.
third step is back your decision and drive forward..
The board has acted quickly to assemble the right skills needed.
They have put out clear and well received information
they have followed it up with a video
they have been actively supporting PAA and the ALS/MND cause on social media
Before all this happened, Michael made it explicitly clear, we are a neurological biotech with an MND / ALS play and we have razor focus on that because it is our best and fastest path to a commercial outcome.
We have “brain in a dish” testing underway to have the preclinical data to support the hypothesis that MPL works beyond MND/ALS
I am sure we will get messages soon from the leadership with affirmation of this focus and the criticality for preclinical work.
keep it coming and keeping going. I like the change.
- Forums
- ASX - By Stock
- PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
the first step to solving a problem is acknowledging you have a...
-
- There are more pages in this discussion • 584 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NUZ (ASX) to my watchlist
(20min delay)
|
|||||
Last
18.5¢ |
Change
-0.015(7.50%) |
Mkt cap ! $90.96M |
Open | High | Low | Value | Volume |
20.0¢ | 20.0¢ | 18.5¢ | $115.7K | 598.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 593392 | 18.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
19.0¢ | 4355 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
9 | 593392 | 0.185 |
8 | 337474 | 0.180 |
5 | 145797 | 0.175 |
4 | 130250 | 0.170 |
1 | 60000 | 0.165 |
Price($) | Vol. | No. |
---|---|---|
0.190 | 4355 | 1 |
0.200 | 77907 | 4 |
0.205 | 109808 | 2 |
0.210 | 147252 | 4 |
0.215 | 100000 | 1 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
NUZ (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online